KRAS and colorectal carcinoma: In aspects of molecular biology, colorectal SRCC presents lower mutation burden in the canonical WNT, MAPK, and PI3K pathways, with most driver genes in conventional CRC (APC, KRAS, and PIK3CA, etc.)being mutated at lower rates in SRCC.